In this week’s episode PODCAST-19, we discuss the news that AstraZeneca’s COVID-19 vaccine trial has been suspended due to a serious side effect for a participant, and how the temporary shutdown from a trial can sometimes mean that the process is working as expected.
Par Anna Rothschild and Sinduja Srinivasan
Don’t want to miss an episode of PODCAST-19, FiveThirtyEight’s weekly look at what we know – and what we know we don’t know – about COVID-19? Subscribe to your favorite podcasting app. For example, here’s where to do it on Podcasts Apple and Spotify.
